Plötzlicher Herztod

Andresen D (2007) Epidemiologie des plötzlichen Herztodes. Wer ist gefährdet? Intensivmed 44: 188–193

Bardy GH, Lee KL, Mark DB et al (2005) Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225–237

Bristow M, Saxon L, Boehmer J et al (2004) Cardiac resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140–2150

Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539–1549

Conolly SJ, Gent M, Roberts S et al (2000) Canadian implantable defibrillator study (CIDS): a randomised trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101: 1297–1302

European Resuscitation Council (2005). Guidelines for resuscitation 2005. Resuscitation 67 (Suppl 1): 1–189

Ezekowitz JA, Armstrong PW, McAllister FA (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomised, controlled trials. Ann Intern Med 138: 445–452

Gorgels APM, Gijsbers C, Vreede-Swagemakers J et al (2003) Out-of-hospital cardiac arrest – the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24: 1204–1209

Julian DG, Camm AJ, Frangin G et al. (1997) Randomised trial of the effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction. EMIAT. Lancet 349: 667–674

Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 351: 2151–2158

Klein HU (2006) Prävention des plötzlichen Herztodes. Internist 47: 1040–1050

Kober L, Block Thomsen PE et al (2000) Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Lancet 356: 2052–2058

Kuck KH, Cappato R, Siebels J et al (2000) Randomised comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 102: 748–754

MERIT-HF-Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet 353: 2001–2007

Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335: 1933–1940

Moss AJ, Zareba W, Hall WJ et al (2002) The Multicenter Automatic Defibrillator Implantation Trial II Investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877–883

Schimpf R, Kuschyk J, Veltamm C et al. (2005) Primär elektrische Herzerkrankungen im Erwachsenenalter – Elektrophysiologische Befunde und Therapie. Herzschr Elektrophys 16: 250–259

The Antiarrhythmics versus Implantzable defibrillators (AVID) investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from nearfatal ventricular arrhythmia. N Engl J Med 337: 1576–1583

Trappe HJ (2005) Frühdefibrillation in USA, Europa und Deutschland. Voraussetzungen, Erfahrungen, Perspektiven. Herzschr Elektrophys 16: 94–102